Dr. Finkelstein has a special interest in the study and patient care and research of a variety of cancers, using radiation driven, and personalized systemic therapy. Accordingly, he holds three International patents in the field of cutting edge technologies.
Dr. Finkelstein has given national and international lectures, published numerous professional journal articles and written book chapters, resulting in over 11,000 literature citations with an H-Index of 42. Additionally, he is renowned in bladder, kidney and testicular cancer as well as lung, breast and skin cancers which he also treats at A.M.P. He also serves on the editorial board of key international journals, including the American Society of Clinical Oncology (ASCO) as the ASCO Associate Editor for Immunotherapy.
For these contributions to patients, Dr. Finkelstein was one of the youngest physicians to receive accelerated fellowship in the American College of Radiation Oncology (ACRO) in 2017 and elected to the ACRO Board of Chancellors and Chair of Education in 2018.